BSX Financial Facts
Selling, general and administrative expenses: 772MGross profit: 1.51B
See Full Income Statement
See Full Balance Sheet
Boston Scientific (BSX) Earnings
|
Expand Research on BSX
| Next EPS Date | 4/24/24 | EPS Growth Rate | +8.5% |
|---|---|---|---|
| Average EPS % Beat Rate | +7.4% | Revenue Growth Rate | +8.6% |
| Average % Move 1-Wk after EPS | +2.2% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
4/24/24  |
Q124 | N/A | $0.51 | N/A | N/A | $3.68B | N/A | N/A | N/A | ||
| 4/20/11 |
 |
Q111 | $0.01 | $0.04 | -$0.03 | $1.93B | $1.9B |  |
 | | Details |
| 7/29/20 | |
Q220 | $0.08 | -$0.02 | +$0.10 | $2B | $1.73B | = | | | Details |
| 2/2/12 |
|
Q411 | $0.13 | $0.08 | +$0.05 | $1.85B | $1.91B | = | | | Details |
| 4/19/12 |
|
Q112 | $0.15 | $0.08 | +$0.07 | $1.87B | $1.86B | = | | | Details |
| 10/20/11 |
|
Q311 | $0.15 | $0.09 | +$0.06 | $1.87B | $1.91B | = | | | Details |
| 10/18/12 |
|
Q312 | $0.16 | $0.11 | +$0.05 | $1.74B | $1.76B | = | | | Details |
| 4/25/13 |
|
Q113 | $0.16 | $0.09 | +$0.07 | $1.76B | $1.79B | = | | | Details |
